Drugs Xagena
The Food and Drug Administration ( FDA ) has approved two new drugs, Tafinlar ( Dabrafenib ) and Mekinist ( Trametinib ), for patients with advanced ( metastatic ) or unresectable melanoma, the most d ...
The FDA ( Food and Drug Administration ) has approved Mekinist ( Trametinib ) in combination with Tafinlar ( Dabrafenib ) to treat patients with advanced melanoma that is unresectable or metastatic.In ...
The FDA ( Food and Drug Administration ) granted Priority Review in metastatic melanoma for the supplemental New Drug Application ( sNDA ) for the combination of Tafinlar ( Dabrafenib ) and Mekinist ( ...
The U.S. Food and Drug Administration ( FDA ) has approved Tafinlar ( Dabrafenib ) and ( Trametinib ), administered together, for the treatment of anaplastic thyroid cancer ( ATC ) that cannot be remo ...
The European Commission has approved Tafinlar ( Dabrafenib ) in combination with Mekinist ( Trametinib ) for the adjuvant treatment of stage III patients with BRAF V600 mutation-positive melanoma afte ...
